1. bookVolume 66 (2016): Edizione 1 (March 2016)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Biphasic dissolution method for quality control and assurance of drugs containing active substances in the form of weak acid salts

Pubblicato online: 07 Mar 2016
Volume & Edizione: Volume 66 (2016) - Edizione 1 (March 2016)
Pagine: 139 - 145
Accettato: 29 Sep 2015
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. United States Pharmacopoeia 38 – National Formulary 33, USP Convention, Rockville (MD) 2015, p. 3869.Search in Google Scholar

2. S. Klein, The use of biorelevant dissolution media to forecast the in vivo performance of a drug, AAPS. J.12 (2010) 397–406; DOI: 10.1208/s12248-010-9203-3.10.1208/s12248-010-9203-3Search in Google Scholar

3. Y. Qiu, Y. Chen, G. Zhang and W. Porter, Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice, Academic Press, London 2009, p. 411.Search in Google Scholar

4. Sirius Analytical Instruments Ltd., New instrument for automated biorelevant biphasic dissolution and solubility testing, Eur. Pharmaceut. Rev. October 2013; http://www.americanpharmaceu-ticalreview.com/22313/news/featured-news-instrument-automated-biorelevant-biphasic-dissolution-solubility-testing/; last access date September 24, 2015.Search in Google Scholar

5. A. Franc and J. Muselik, Method for Preparing Solid Drug from Warfarin Sodium Salt in Form of Isopropanol Clathrate, Involves Determining Total Weight of Solid Drug and Distribution Ratio of Warfarin Sodium Salt, Pat. CZ304136-B6, October 2013.Search in Google Scholar

6. J. Muselik, A. Franc, P. Dolezel, R. Gonec, A. Krondlova and I. Lukasova, Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP, Acta Pharm.64 (2014) 355–367; DOI: 10.2478/ACPH-2014-0022.10.2478/acph-2014-0022Search in Google Scholar

7. L. M. Vercaigne and G. G. Zhanel, Clinical significance of bioequivalence and interchangeability of narrow therapeutic range drugs: focus on warfarins, J. Pharm. Pharm. Sci.1 (1998) 92–94.Search in Google Scholar

8. V. R. S. Uppoor, Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations, J. Control. Release72 (2001) 127–132; DOI: 10.1016/S0168-3659(01)00268-1.10.1016/S0168-3659(01)00268-1Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo